These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2877074)

  • 1. Chronic subcutaneous treatment with acebutolol: haemodynamic effects and metabolism in spontaneously hypertensive rats.
    Heimburger M; Davy M; Midol-Monnet M; Beslot F; Cohen Y
    J Pharm Pharmacol; 1986 Sep; 38(9):699-702. PubMed ID: 2877074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute haemodynamic effects and tissue distribution of acebutolol in normotensive and spontaneously hypertensive rats.
    Midol-Monnet M; Heimburger M; Davy M; Beslot F; Wepierre J; Cohen Y; Barre J
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 82(1):75-9. PubMed ID: 2865078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of acebutolol, a cardioselective beta-adrenoceptor blocking agent, on the blood pressure in rats (author's transl)].
    Takami N; Sugawara K; Ozaki M
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):747-54. PubMed ID: 44260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between beta blockers and epinephrine on hemodynamics of spontaneously hypertensive rats.
    Kim Y
    Res Commun Chem Pathol Pharmacol; 1993 Apr; 80(1):3-19. PubMed ID: 8488340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of acebutolol and practolol on the lipolytic response to isoprenaline.
    Gibbons DO; Lant AF; Ashford A; Collins RF; Pinder S
    Br J Clin Pharmacol; 1976 Feb; 3(1):177-84. PubMed ID: 973938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies on the pharmacological properties of diacetolol, the major metabolite of acebutolol in man.
    Borchard U; Hafner D; Hirth C
    Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):4-17. PubMed ID: 2860878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on the clinical pharmacology and plasma concentrations of diacetolol, the major human metabolite of acebutolol.
    Ohashi K; Warrington SJ; Kaye CM; Houghton GW; Dennis M; Templeton R; Turner P
    Br J Clin Pharmacol; 1981 Oct; 12(4):561-5. PubMed ID: 7295489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
    Bunting MW; Widdop RE
    Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution of acebutolol in mature normotensive and stroke-prone spontaneously hypertensive rats.
    Midol-Monnet M; Heimburger M; Davy M; Beslot F; Cohen Y
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 87(1):83-6. PubMed ID: 2885145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between irbesartan, peroxisome proliferator-activated receptor (PPAR-γ), and adiponectin in the regulation of blood pressure and renal function in spontaneously hypertensive rats.
    Afzal S; Sattar MA; Johns EJ; Abdulla MH; Akhtar S; Hashmi F; Abdullah NA
    J Physiol Biochem; 2016 Dec; 72(4):593-604. PubMed ID: 27405250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of oral acebutolol and propranolol on forearm blood flow in hypertensive patients.
    Ireland MA; Littler WA
    Br J Clin Pharmacol; 1981 Sep; 12(3):363-8. PubMed ID: 7295466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative pharmacokinetic and pharmacodynamic study of conventional and sustained-release preparations of acebutolol in healthy volunteers.
    Fleurot O; Lecocq B; Lecocq V; Le Liboux A; Montay G; Frydman A; Jaillon P
    Fundam Clin Pharmacol; 1991; 5(7):601-9. PubMed ID: 1778538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of acebutolol and propranolol in hypertensive patients during exercise.
    Reim HG; Wagner W
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):238-43. PubMed ID: 4008112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats.
    Bunting MW; Widdop RE
    Eur J Pharmacol; 1999 Sep; 381(1):13-21. PubMed ID: 10528129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of arterial relaxation by long-term atenolol treatment in spontaneously hypertensive rats.
    Kähönen M; Mäkynen H; Arvola P; Pörsti I
    Br J Pharmacol; 1994 Jul; 112(3):925-33. PubMed ID: 7921622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.).
    Gulaid AA; James IM; Kaye CM; Lewellen OR; Roberts E; Sankey M; Smith J; Templeton R; Thomas RJ
    Biopharm Drug Dispos; 1981; 2(2):103-14. PubMed ID: 7248475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.
    Flouvat B; Roux A; Chau NP; Viallet M; Andre-Fouet X; Woehrle R; Gregoire J
    Eur J Clin Pharmacol; 1981 Mar; 19(4):287-92. PubMed ID: 7286031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Ang II and renal sympathetic nerve influence dopamine-and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats.
    Abdulla MH; Sattar MA; Abdullah NA; Hazim AI; Anand Swarup KR; Rathore HA; Khan MA; Johns EJ
    Auton Autacoid Pharmacol; 2008 Oct; 28(4):95-101. PubMed ID: 18778332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.